Brain tumor patients may avoid seizures with simple drug
NCT ID NCT07130786
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether the seizure drug levetiracetam (Keppra) can prevent first-time seizures in people with brain metastases located in the motor cortex. About 150 adults who have never had a seizure will be randomly assigned to take the drug or receive standard care. The goal is to see if the drug lowers the chance of having a seizure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN METASTASES FROM EXTRA-CRANIAL SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Brigham and Women's Hospital
RECRUITINGBoston, Massachusetts, 02115, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Sound waves and microbubbles: a new key to the Brain's locked door?
- Brain wave battle: deeper suppression may halt post-arrest seizures
- Seizure drug may shield the brain after cardiac arrest — a trial puts it to the test
- Brain surgery meets brain science: probing how a memory-related chemical system influences cognition
- Sleep and seizures: new study probes why stroke triggers epilepsy in some patients
- Brain seizures in sick kids: can better monitoring save lives?